Disruptions of Anaerobic Gut Bacteria Are Associated with Stroke and Post-stroke Infection: a Prospective Case-Control Study
Overview
Authors
Affiliations
In recent years, preclinical studies have illustrated the potential role of intestinal bacterial composition in the risk of stroke and post-stroke infections. The results of these studies suggest that bacteria capable of producing volatile metabolites, including trimethylamine-N-oxide (TMAO) and butyrate, play opposing, yet important roles in the cascade of events leading to stroke. However, no large-scale studies have been undertaken to determine the abundance of these bacterial communities in stroke patients and to assess the impact of disrupted compositions of the intestinal microbiota on patient outcomes. In this prospective case-control study, rectal swabs from 349 ischemic and hemorrhagic stroke patients (median age, 71 years; IQR: 67-75) were collected within 24 h of hospital admission. Samples were subjected to 16S rRNA amplicon sequencing and subsequently compared with samples obtained from 51 outpatient age- and sex-matched controls (median age, 72 years; IQR, 62-80) with similar cardiovascular risk profiles but without active signs of stroke. Plasma protein biomarkers were analyzed using a combination of nuclear magnetic resonance (NMR) spectroscopy and liquid chromatography-mass spectrometry (LC-MS). Alpha and beta diversity analyses revealed higher disruption of intestinal communities during ischemic and hemorrhagic stroke compared with non-stroke matched control subjects. Additionally, we observed an enrichment of bacteria implicated in TMAO production and a loss of butyrate-producing bacteria. Stroke patients displayed two-fold lower plasma levels of TMAO than controls (median 1.97 vs 4.03 μM, Wilcoxon p < 0.0001). Finally, lower abundance of butyrate-producing bacteria within 24 h of hospital admission was an independent predictor of enhanced risk of post-stroke infection (odds ratio 0.77, p = 0.005), but not of mortality or functional patient outcome. In conclusion, aberrations in trimethylamine- and butyrate-producing gut bacteria are associated with stroke and stroke-associated infections.
Dietary herbs that interact with gut microbiota: roles as anti-stroke agents.
Li X, Liu S, Wang F, Li X, Liu H, Lian T Food Sci Biotechnol. 2025; 34(3):547-562.
PMID: 39958164 PMC: 11822190. DOI: 10.1007/s10068-024-01698-7.
Gut Microbiota, Bacterial Translocation, and Stroke: Current Knowledge and Future Directions.
Granados-Martinez C, Alfageme-Lopez N, Navarro-Oviedo M, Nieto-Vaquero C, Cuartero M, Diaz-Benito B Biomedicines. 2025; 12(12.
PMID: 39767686 PMC: 11673227. DOI: 10.3390/biomedicines12122781.
Bonnechere B Biomimetics (Basel). 2024; 9(12).
PMID: 39727727 PMC: 11673090. DOI: 10.3390/biomimetics9120723.
Functional Outcome Prediction of Acute Ischemic Stroke Based on the Oral and Gut Microbiota.
Liang J, Ren Y, Zheng Y, Lin X, Song W, Zhu J Mol Neurobiol. 2024; .
PMID: 39546118 DOI: 10.1007/s12035-024-04618-2.
Rahimi A, Qaisar S, Janeh T, Karimpour H, Darbandi M, Moludi J Sci Rep. 2024; 14(1):24021.
PMID: 39402150 PMC: 11473548. DOI: 10.1038/s41598-024-76153-y.